AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 121 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $708,000 | +13.8% | 75,283 | -7.4% | 0.00% | – |
Q2 2020 | $622,000 | +34.3% | 81,273 | +8.5% | 0.00% | – |
Q1 2020 | $463,000 | -49.2% | 74,903 | +0.1% | 0.00% | -100.0% |
Q4 2019 | $911,000 | -7.5% | 74,853 | -12.2% | 0.00% | 0.0% |
Q3 2019 | $985,000 | +16.0% | 85,253 | +0.4% | 0.00% | 0.0% |
Q2 2019 | $849,000 | +10.5% | 84,953 | +42.4% | 0.00% | – |
Q1 2019 | $768,000 | -15.2% | 59,653 | 0.0% | 0.00% | -100.0% |
Q4 2018 | $906,000 | -24.1% | 59,653 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $1,193,000 | -4.9% | 59,653 | -7.3% | 0.00% | 0.0% |
Q2 2018 | $1,255,000 | -0.2% | 64,363 | +3.1% | 0.00% | 0.0% |
Q1 2018 | $1,258,000 | +95.6% | 62,443 | +28.6% | 0.00% | – |
Q4 2017 | $643,000 | -42.3% | 48,553 | -19.6% | 0.00% | -100.0% |
Q3 2017 | $1,114,000 | +0.4% | 60,353 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $1,110,000 | -51.3% | 60,353 | -40.3% | 0.00% | -50.0% |
Q1 2017 | $2,280,000 | -60.6% | 101,123 | -39.2% | 0.00% | -60.0% |
Q4 2016 | $5,784,000 | +32.0% | 166,203 | -7.1% | 0.01% | +25.0% |
Q3 2016 | $4,383,000 | +185.5% | 178,813 | +178.6% | 0.00% | +300.0% |
Q2 2016 | $1,535,000 | +18.1% | 64,173 | +15.5% | 0.00% | 0.0% |
Q1 2016 | $1,300,000 | -22.5% | 55,573 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $1,678,000 | -25.5% | 55,573 | -1.9% | 0.00% | -50.0% |
Q3 2015 | $2,251,000 | -38.1% | 56,663 | +7.6% | 0.00% | -33.3% |
Q2 2015 | $3,638,000 | +49.7% | 52,673 | +18.4% | 0.00% | +50.0% |
Q1 2015 | $2,431,000 | +28.3% | 44,473 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $1,895,000 | +43.6% | 44,473 | +7.5% | 0.00% | +100.0% |
Q3 2014 | $1,320,000 | +71.0% | 41,373 | +11.0% | 0.00% | 0.0% |
Q2 2014 | $772,000 | +6.6% | 37,273 | -0.4% | 0.00% | 0.0% |
Q1 2014 | $724,000 | -31.6% | 37,410 | -14.3% | 0.00% | 0.0% |
Q4 2013 | $1,059,000 | +13.0% | 43,627 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $937,000 | -4.9% | 43,627 | -1.4% | 0.00% | 0.0% |
Q2 2013 | $985,000 | – | 44,253 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 740,585 | $17,330,000 | 8.11% |
Palo Alto Investors LP | 2,906,194 | $68,005,000 | 5.28% |
Opaleye Management Inc. | 220,000 | $5,148,000 | 3.21% |
Endurant Capital Management LP | 265,180 | $6,205,000 | 2.01% |
FALCON POINT CAPITAL, LLC | 381,081 | $8,917,000 | 1.54% |
STELLIAM INVESTMENT MANAGEMENT, LP | 1,470,000 | $34,398,000 | 1.06% |
AlphaOne Investment Services, LLC | 91,824 | $2,149,000 | 0.88% |
ASHFORD CAPITAL MANAGEMENT INC | 153,325 | $3,588,000 | 0.85% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 55,097 | $1,289,000 | 0.84% |
Camber Capital Management LP | 600,000 | $14,040,000 | 0.82% |